Navigation Links
ATS Medical Announces Participation in the Annual Meeting of the American Association for Thoracic Surgeons
Date:5/8/2008

MINNEAPOLIS, May 8 /PRNewswire-FirstCall/ -- ATS Medical, Inc. (Nasdaq: ATSI), manufacturer and marketer of state-of-the-art cardiac surgery products and services, today announced participation in the upcoming Annual Meeting of the American Association for Thoracic Surgeons. One of the key gatherings of cardiovascular surgeons from around the world, the event is being held in San Diego from May 10-14, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040202/ATSILOGO)

The AATS meeting provides an excellent opportunity to demonstrate the progress made by ATS Medical in assembling an array of product offerings focused on the evolving needs of cardiac surgeons. The exhibition will feature the company's flagship ATS Open Pivot(R) Heart Valve and its newest advancement, the ATS Open Pivot(R) AP360(TM). The AP360 combines the fundamental strengths of the open pivot design with a new cuff that maximizes hemodynamic performance and extends the valve's appeal to a broader range of surgeon preferences.

The ATS 3f(R) Aortic Bioprosthesis will be the highlight of the exhibition. Professor Sven Martens from the JW Goethes University in Frankfurt will be presenting his "Single Center Experience with the ATS 3f(R) Enable(TM) Aortic Bioprosthesis" at the ATS booth on May 12 and 13.

The ATS Simulus(R) annuloplasty product line, designed for the heart valve repair market segment, will be showcased with special focus on the new ATS Simulus Semi-Rigid Annuloplasty Ring. Scott Goldman, M.D., from Lankenau Hospital in Philadelphia, will present his "Experience with ATS Simulus Annuloplasty Products and the ATS CryoMaze(TM) Surgical Ablation System" on Monday, May 12 during an in-booth presentation.

Atrial fibrillation is expected to be a key growth driver in 2008 and beyond. The ATS CryoMaze(TM) Surgical Ablation System, proven to yield clinical results similar to t
'/>"/>

SOURCE ATS Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Culturesmart(TM) Breaks Language Barriers With Trained Medical Interpreters
2. Vail Valley Medical Center Board of Directors Announces Appointment of New President & CEO, John Cassin
3. Select Medical Corporation to Announce First Quarter Results on Thursday, May 15
4. Boston Medical Center/Boston University School of Medicine researcher receives award
5. Prisoner HIV program leads to continuum of medical care after release
6. Weill Cornell Medical College Announces First Commencement of Its New Medical School Graduates in Doha, Qatar, May 8, 2008
7. Medical research is essential to improving the economy and bettering lives
8. KePROs Chief Medical Officer to Deliver Clinical Keynote Address
9. ABQAURP Hosts Third Annual Medical Management Conference in Orlando
10. Warren F. Muth, MD, to Serve as President of Ohio State Medical Association
11. BioForm Medical Announces Extension of Lock-Up Period
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 2China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010 3New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 2Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 3Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 4Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite 5Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 1Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 2Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW 4513 3JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 1JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 2JLL Announces Extension of Its Offer to Acquire Patheon and Take Up of Deposited Restricted Voting Shares 47583 3Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 1Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 2Streamline Health to Announce First Quarter Fiscal Year 2009 Financial Results on Tuesday June 9 2009 47582 3